Search results
Results from the WOW.Com Content Network
Somapacitan is the first human growth hormone (hGH) therapy that adults only take once a week by injection under the skin; other FDA-approved hGH formulations for adults with growth hormone deficiency must be administered daily. [10] It contains a small non-covalent moiety that reversibly binds to serum albumin which slows down elimination. [15]
In adults, wasting (or cachexia) caused by AIDS. [13] Turner syndrome epitomizes the response of non-deficient shortness. At doses 20% higher than those used in GH deficiency, growth accelerates. With several years of treatment the median gain in adult height is about 5-8 cm on this dose. The gains appear to be dose-dependent. [14]
The main growth hormone produced by recombinant DNA technology has the approved generic name somatropin and the brand name Humatrope [4] and is properly abbreviated rhGH in the scientific literature. Since its introduction in 1992, Humatrope has been a banned sports doping agent [ 5 ] and in this context is referred to as HGH.
"Provocative tests" involve giving a dose of an agent that will normally provoke a pituitary to release a burst of growth hormone. An intravenous line is established, the agent is given, and small amounts of blood are drawn at 15-minute intervals over the next hour to determine if a rise of GH was provoked.
Lonapegsomatropin, sold under the brand name Skytrofa, is a human growth hormone used for the treatment of growth hormone deficiency. [1] [3] Lonapegsomatropin is a prodrug of somatropin.
Dehydration tends to be more common older adults, Shapses says, and the Centers for Disease Control and Prevention (CDC) says that their water intake is "significantly lower" than other adult age ...
By 2050, the number of Americans age 65 and older is expected to surge by 47%, and — for the first time in Oklahoma history — the number of adults age 60 and older will outnumber children by 2034.
The QoL-AGHDA was published in 1999 and was funded by Pharmacia & Upjohn AB, Sweden. [4] The research company that developed the QoL-AGHDA was Galen Research. [5] The measure was originally created for use in UK English, Swedish, Italian, German and Spanish, but later on it was also adapted for the United States, Belgium, the Netherlands, Brazil and Denmark.